US2015141354A1PendingUtilityA1

Glycoside derivatives and uses thereof

Assignee: BEBERNITZ GREGORY RAYMONDPriority: Oct 20, 2009Filed: Jan 23, 2015Published: May 21, 2015

Est. expiryOct 20, 2029(~3.2 yrs left)· nominal 20-yr term from priority

Inventors:Gregory Raymond Bebernitz Mark G. Bock Dumbala Srinivas Reddy Atul Kashinath Hajare Vinod Vyavahare Sandeep Bhausaheb Bhosale Suresh Eknath Kurhade Videsh Salunkhe Nadim S. Shaikh Debnath Bhuniya P. Venkata Palle Lili Feng Jessica Liang

A61P 3/06A61P 7/02A61P 3/10A61P 9/12A61P 3/08A61P 3/04A61P 3/00A61P 19/06A61K 31/7052A61K 31/7048C07H 7/04C07D 407/10C07D 413/10A61K 31/706C07D 405/10A61K 31/70

PatentIndex Score

Cited by

References

Claims

Abstract

This invention relates to compounds represented by formula (I): wherein the variables are defined as herein above, which are useful for treating diseases and conditions mediated by the sodium D-glucose co-transporter (SGLT), e.g. diabetes. The invention also provides methods of treating such diseases and conditions, and compositions etc. for their treatment.

Claims

exact text as granted — not AI-modified

We claim: 
     
         1 . A method of treating obesity, comprising administering to a mammal in need thereof a therapeutically effective amount of the compound: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         2 . A method of treating obesity, comprising administering to a mammal in need thereof a therapeutically effective amount of the compound: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         3 . A method of treating obesity, comprising administering to a mammal in need thereof a therapeutically effective amount of the compound: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof. 
     
     
         4 . A method of treating obesity, comprising administering to a mammal in need thereof a therapeutically effective amount of the compound: 
       
         
           
           
               
               
           
         
       
       or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2015141354A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.